Patents by Inventor Eric F. Fisher

Eric F. Fisher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Truncated soluble tumor necrosis factor type-I and type-II receptors
    Patent number: 6989147
    Abstract: Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: January 24, 2006
    Assignee: Amgen Inc.
    Inventors: Eric F. Fisher, Carl K. Edwards, III, Gary L. Kieft
  • Truncated soluble tumor necrosis factor type-I and type-II receptors
    Publication number: 20030054439
    Abstract: Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.
    Type: Application
    Filed: June 15, 2001
    Publication date: March 20, 2003
    Applicant: Amgen Inc.
    Inventors: Eric F. Fisher, Carl K. Edwards, Gary L. Kieft
  • Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
    Patent number: 5625050
    Abstract: The present invention provides nuclease resistant 3'-carbon modified oligonucleotides that can be used in the field of nucleic acid therapeutics and diagnostics. The modified oligonucleotides of the present invention have at least one modified internucleotide linkage wherein the divalent oxygen moiety at the 3'-position of the internucleotide linkage is replaced by a tetravalent carbon moiety. The 3'-carbon modified internucleotide linkage is preferably a 3'-methylene or 3'-hydroxymethylene linkage. Also provided are a method and monomeric nucleoside and nucleotide intermediates for making the modified oligonucleotides of the present invention.
    Type: Grant
    Filed: March 31, 1994
    Date of Patent: April 29, 1997
    Assignee: Amgen Inc.
    Inventors: Graham Beaton, Eric F. Fisher
  • System for biotin synthesis
    Patent number: 5110731
    Abstract: A system for the production of biotin wherein a biotin retention-deficient strain of a cell is transformed with plasmid bearing the biotin gene cluster bio (A, B, F, C and D). The media of cultures of the resulting cells contains enhanced amounts of biotin by comparison with similar constructions in strains capable of biotin retention.
    Type: Grant
    Filed: June 13, 1990
    Date of Patent: May 5, 1992
    Assignee: Amgen, Inc.
    Inventor: Eric F. Fisher